Cargando…
An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer
It is now widely established that management of lung cancer is much more complex and cannot be centered on the binary classification of small-cell versus non-small cell lung cancer (NSCLC). Lung cancer is now recognized as a highly heterogeneous disease that develops from genetic mutations and gene...
Autores principales: | Ahmadzada, Tamkin, Kao, Steven, Reid, Glen, Boyer, Michael, Mahar, Annabelle, Cooper, Wendy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025105/ https://www.ncbi.nlm.nih.gov/pubmed/29914100 http://dx.doi.org/10.3390/jcm7060153 |
Ejemplares similares
-
Small and Large Extracellular Vesicles Derived from Pleural Mesothelioma Cell Lines Offer Biomarker Potential
por: Ahmadzada, Tamkin, et al.
Publicado: (2023) -
Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms
por: Barnet, Megan B., et al.
Publicado: (2018) -
Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population
por: Ahmadzada, Tamkin, et al.
Publicado: (2020) -
Targeted Molecular Treatments in Non-Small Cell Lung Cancer: A Clinical Guide for Oncologists
por: Bui, Kim Tam, et al.
Publicado: (2018) -
Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse
por: Lim, Jeong Uk
Publicado: (2023)